
Auteur C. KERVRAN
|
Documents disponibles écrits par cet auteur (6)

C. KERVRAN ; D. SHMULEWITZ ; F. SERRE ; C. DENIS ; P. ROUX ; M. JAUFFRET-ROUSTIDE ; L. LALANNE ; D. HASIN ; M. AURIACOMBE | 2021
Dans Addictive Behaviors (Vol.116, May 2021) Article : PériodiqueAim: To examine differences in the psychometric characteristics of diagnostic criteria for Substance Use Disorders (SUD) between substance users in harm reduction settings (HR) and substance users seeking treatment (Tx). Methods: Differential I[...]
L. LALANNE ; P. ROUX ; C. DONADILLE ; L. BRIAND MADRID ; I. CELERIER ; C. CHAUVIN ; N. HAMELIN ; C. KERVRAN ; G. MARADAN ; M. AURIACOMBE ; M. JAUFFRET-ROUSTIDE ; The COSINUS Study Group | 2024
Dans Addiction (Vol.119, n°1, January 2024) Article : PériodiqueAims: The primary aim of this study was to evaluate the impact of drug consumption rooms (DCRs) in France on injection equipment-sharing, while the secondary aims focused upon their impact on access to hepatitis C virus (HCV) testing and opioid [...]
M. AURIACOMBE ; P. ROUX ; L. BRIAND MADRID ; S. KIRCHHERR ; C. KERVRAN ; C. CHAUVIN ; M. GUTOWSKI ; C. DENIS ; M. P. CARRIERI ; L. LALANNE ; M. JAUFFRET-ROUSTIDE ; The COSINUS Study Group | 2019
Dans BMJ Open (Vol.9, n°2, February 2019) Article : PériodiqueIntroduction: The high prevalence of hepatitis C and the persistence of HIV and hepatitis C virus (HCV) risk practices in people who inject drugs (PWID) in France underlines the need for innovative prevention interventions. The main objective of[...]
M. BOUDARD ; J. M. ALEXANDRE ; C. KERVRAN ; L. JAKUBIEC ; D. SHMULEWITZ ; D. HASIN ; L. FOURNET ; C. RASSIS ; P. CLAVERIE ; F. SERRE ; M. AURIACOMBE | 2022
Dans Journal of Medical Internet Research (Vol.24, n°7, July 2022) Article : PériodiqueBackground: Screen use is part of daily life worldwide and morbidity related to excess use of screens has been reported. Some use of screens in excess could indicate a screen use disorder (ScUD). An integrative approach to ScUD could better fit [...]
L. LALANNE ; J. R. DAVALOS ; M. AUDRAN ; N. HAMELIN ; C. CHAUVIN ; L. BRIAND-MADRID ; C. KERVRAN ; S. KIRCHHERR ; M. AURIACOMBE ; P. ROUX ; M. JAUFFRET-ROUSTIDE ; The COSINUS Study Group | 2025
Dans Substance Use and Misuse (Vol.60, n°3, 2025) Article : PériodiqueBACKGROUND: Opioid Use Disorder (OUD) often provokes dramatic consequences in terms of increased morbi-mortality. Two medications have mainly been worldwide used for OUD (MOUD), buprenorphine and methadone. Recently, however, some reports have h[...]
C. GAULD ; E. BAILLET ; J. A. MICOULAUD-FRANCHI ; C. KERVRAN ; F. SERRE ; M. AURIACOMBE | 2023
Dans Drug and Alcohol Dependence (Vol.245, April 2023) Article : PériodiqueBackground and aims: Among the 11 current diagnostic criteria, craving is a potential central marker for understanding and for treatment of Substance Use Disorders (SUD). Our objective was to explore craving centrality across SUD based on the st[...]